Published in Ann Rheum Dis on February 04, 2005
Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res Ther (2007) 1.83
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int (2011) 1.12
Transforming growth factor β 869C/T and interleukin 6 -174G/C polymorphisms relate to the severity and progression of bone-erosive damage detected by ultrasound in rheumatoid arthritis. Arthritis Res Ther (2011) 0.89
Transforming growth factor beta1 gene variation Leu10Pro affects secretion and function in hepatic cells. Dig Dis Sci (2012) 0.82
Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications. World J Orthop (2014) 0.82
Promoter polymorphism of transforming growth factor-beta1 gene and ulcerative colitis. World J Gastroenterol (2008) 0.80
The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-β1 serum levels but not with G915C (Arg25Pro) TGF-β1 polymorphism. Rheumatol Int (2010) 0.78
Higher expression of latency-associated peptide on the surface of peripheral blood monocytes in patients with rheumatoid arthritis may be protective against articular erosions. Inflammation (2013) 0.78
Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy. Autoimmun Rev (2012) 0.77
Interaction between smoking and functional polymorphism in the TGFB1 gene is associated with ischaemic heart disease and myocardial infarction in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2012) 0.75
A functional polymorphism C-509T in TGFβ-1 promoter contributes to susceptibility and prognosis of lone atrial fibrillation in Chinese population. PLoS One (2014) 0.75
Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone. Front Immunol (2012) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Measurement of patient outcome in arthritis. Arthritis Rheum (1980) 21.31
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum (1987) 14.21
Role of transforming growth factor beta in human disease. N Engl J Med (2000) 10.17
Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) (1977) 9.55
Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet (1999) 3.08
A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res (2003) 2.21
A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun (2002) 2.21
TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax (2000) 2.14
Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med (2003) 1.98
Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum (2000) 1.81
Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med (1989) 1.77
Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatology (Oxford) (2001) 1.70
ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol (1999) 1.68
Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation (2000) 1.59
Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study. Arthritis Rheum (2002) 1.57
Transforming growth factor beta1 gene polymorphism in rheumatoid arthritis. Ann Rheum Dis (2002) 1.54
Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum (1999) 1.50
Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax (2004) 1.39
Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res (1998) 1.37
IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun (2001) 1.25
Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures. Clin Exp Immunol (1990) 1.21
CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun (2000) 1.17
Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res (2004) 1.17
Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest (1994) 1.08
Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med (2003) 1.05
Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis (2002) 1.03
Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women. Breast Cancer (2003) 1.00
T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev (2004) 0.98
The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk. Cancer Lett (2003) 0.95
Association of transforming growth factor-beta1 (TGFbeta1) T29 --> C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal german women. Calcif Tissue Int (2001) 0.95
Immunoglobulin G fc-receptor (FcgammaR) IIA, IIIA, and IIIB polymorphisms related to disease severity in rheumatoid arthritis. J Rheumatol (2002) 0.94
Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney Int (2003) 0.92
Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. Carcinogenesis (2003) 0.88
No association between the TGF-beta 1 Leu10Pro polymorphism and osteoporosis among white women in the United States. Am J Med (2003) 0.87
Osteoporosis and transforming growth factor-beta-1 gene polymorphism in Chinese men and women. J Bone Miner Metab (2004) 0.86
A DNA polymorphism at the alpha2-macroglobulin gene is associated with the severity of rheumatoid arthritis. J Rheumatol (2000) 0.85
The relationship between serial measures of disease activity and outcome in rheumatoid arthritis. Q J Med (1993) 0.84
The T869C TGF beta polymorphism is associated with fracture, bone mineral density, and calcaneal quantitative ultrasound in elderly women. Bone (2003) 0.83
Association of NRAMP1 promoter gene polymorphism with the susceptibility and radiological severity of rheumatoid arthritis. Tissue Antigens (2002) 0.83
Relationship of polymorphisms of the Interleukin-1 gene cluster to occurrence and severity of rheumatoid arthritis. Tissue Antigens (2002) 0.82
Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis. Genes Immun (1999) 0.82
Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes. Arthritis Rheum (2000) 0.80
Transforming growth factor beta 1 gene (HSTGFB1) nucleotide T869C (codon 10) polymorphism is not associated with prevalence or severity of rheumatoid arthritis in a Caucasian population. Ann Rheum Dis (2003) 0.78
Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res (1997) 3.54
Residual symptoms after partial remission: an important outcome in depression. Psychol Med (1995) 3.23
The process of metastasisation for breast cancer. Eur J Cancer (2003) 2.30
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) (2000) 2.19
Clinical and economic choices in anaesthesia for day surgery: a prospective randomised controlled trial. Anaesthesia (2003) 2.08
Propofol and halothane versus sevoflurane in paediatric day-case surgery: induction and recovery characteristics. Br J Anaesth (2003) 1.78
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer (2002) 1.77
Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatology (Oxford) (2001) 1.70
Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term? Rheumatology (Oxford) (2000) 1.67
Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol (1986) 1.64
Male pelvic anatomy reconstructed from the visible human data set. J Urol (1998) 1.59
Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res (1996) 1.47
Laparoscopic oophorectomy in children. J Laparoendosc Surg (1996) 1.42
Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol (1996) 1.42
Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol (1998) 1.40
Oestrogen sulfotransferase: molecular cloning and sequencing of cDNA for the bovine placental enzyme. Aust J Biol Sci (1988) 1.32
The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. Br J Rheumatol (1991) 1.25
HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. J Rheumatol (2001) 1.25
Molecular mechanics calculations of the structures of polyamide nucleic acid DNA duplexes and triple helical hybrids. Proc Natl Acad Sci U S A (1993) 1.20
Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene (1992) 1.20
The reliability of the three-dimensional FASTRAK measurement system in measuring cervical spine and shoulder range of motion in healthy subjects. Rheumatology (Oxford) (2000) 1.19
Radiographic patterns and response to corticosteroid hip injection. Ann Rheum Dis (1997) 1.18
Coeliac disease presenting as recurrent pericarditis. Lancet (1981) 1.18
Anti-rheumatic drugs and joint damage in rheumatoid arthritis. Q J Med (1985) 1.17
Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Arthritis Rheum (2001) 1.17
Clinical value of ELISA assays for IgM and IgG rheumatoid factors. J Clin Pathol (1987) 1.15
Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Ann Rheum Dis (1997) 1.14
Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapy. Ann Rheum Dis (1986) 1.11
Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients. Eur J Surg Oncol (2005) 1.11
Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol (1996) 1.10
Food outlet visits, physical activity and body weight: variations by gender and race-ethnicity. Br J Sports Med (2008) 1.08
A cluster of Legionnaires' disease caused by Legionella longbeachae linked to potting compost in Scotland, 2008-2009. Euro Surveill (2010) 1.07
Serum matrix metalloproteinase 3 as a predictor of joint destruction in rheumatoid arthritis: comment on the article by Yamanaka et al. Arthritis Rheum (2000) 1.07
Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components. Lab Invest (1997) 1.07
The GALS locomotor screen and disability. Ann Rheum Dis (1993) 1.07
Clinical markers of serious illness in young infants: a multicentre follow-up study. J Paediatr Child Health (2000) 1.04
Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin. Br J Rheumatol (1989) 1.04
Association of polymorphism in glutathione S-transferase loci with susceptibility and outcome in rheumatoid arthritis: comparison with the shared epitope. Ann Rheum Dis (1999) 1.01
Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of a 100 mg slow-release formulation. Eur J Clin Pharmacol (1986) 1.01
Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity. Ann Rheum Dis (1994) 1.01
Gonococcal arthritis: an unusual presentation as pseudothrombophlebitis. Ann Rheum Dis (1985) 1.00
Measurement and prediction of radiological progression in early rheumatoid arthritis. J Rheumatol (1994) 0.99
Survival from accidental strangulation from a scarf resulting in laryngeal rupture and carotid artery stenosis: the "Isadora Duncan syndrome". A case report and review of literature. Emerg Med J (2003) 0.99
Thoracoscopic management of empyema in children. J Laparoendosc Surg (1996) 0.98
Spontaneous haemarthrosis following thrombolytic therapy for myocardial infarction. Postgrad Med J (1990) 0.97
Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) (2002) 0.96
Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) (2004) 0.95
High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis. J Rheumatol (2000) 0.95
Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors. Am J Hum Genet (1994) 0.94
Tissue typing in brucellosis. Ann Rheum Dis (1985) 0.94
Are we ready for NICE head injury guidelines in Scotland? Emerg Med J (2004) 0.94
How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study. Clin Rheumatol (2000) 0.94
Consequences of the combined loss of BOK and BAK or BOK and BAX. Cell Death Dis (2013) 0.94
Patient-assessed health in ankylosing spondylitis: a structured review. Rheumatology (Oxford) (2005) 0.94
Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) (2002) 0.93
Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun (2004) 0.92
Medical audit: the differing perspectives of managers and clinicians. J R Coll Physicians Lond (1992) 0.92
The effect of anaesthetic agents on induction, recovery and patient preferences in adult day case surgery: a 7-day follow-up randomized controlled trial. Eur J Anaesthesiol (2008) 0.91
Development and preliminary assessment of a simple measure of overall status in rheumatoid arthritis (OSRA) for routine clinical use. QJM (1995) 0.90
Effect of central administration of QRFP(26) peptide on energy balance and characterization of a second QRFP receptor in rat. Brain Res (2006) 0.90
A phase I study of irinotecan administered on a weekly schedule in pediatric patients. Pediatr Blood Cancer (2006) 0.90
Primary care--the educational need. Br J Rheumatol (1990) 0.90
Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours. Int J Cancer (1997) 0.90
Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas. Oncogene (1998) 0.89
Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Genes Chromosomes Cancer (1997) 0.89
Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment. Clin Rheumatol (1991) 0.89
No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms. Gynecol Oncol (1998) 0.88
Demonstration of cytokeratin in endothelial cells of the synovial microvasculature in situ and in vitro. Br J Rheumatol (1993) 0.87
A state-based immunization campaign: the New Mexico experience. J Sch Health (1997) 0.87
Reaction time and prognosis in acute schizophrenia. J Nerv Ment Dis (1971) 0.87
Massive eosinophilia in rheumatoid arthritis: report of four cases. Clin Rheumatol (1986) 0.87
Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis. Br J Rheumatol (1990) 0.86
Influence of variations across the MMP-1 and -3 genes on the serum levels of MMP-1 and -3 and disease activity in rheumatoid arthritis. Genes Immun (2011) 0.86
Perceived risk of bovine spongiform encephalopathy and dietary behavior. J Health Psychol (2003) 0.86
Comparison of IgA-alpha1-antitrypsin levels in rheumatoid arthritis and seronegative oligoarthritis: complex formation is not associated with inflammation per se. Br J Rheumatol (1998) 0.86
Multiple joint avascular necrosis: beware of tuberculosis and human immunodeficiency virus--a rare but important cause. Br J Rheumatol (1995) 0.86
Increased expression of the NME1 gene is associated with metastasis in epithelial ovarian cancer. Int J Cancer (1995) 0.86
Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study. Br J Rheumatol (1989) 0.86
Endocrine and exocrine pancreatic function in treated coeliac disease. Pancreas (1986) 0.86
Optimization of a Rayleigh-type equation for the detection of tritanomaly. Vision Res (1979) 0.86
Improving the response to gold or D-penicillamine by addition of sulphasalazine. A pilot study in 25 patients with rheumatoid arthritis. Clin Exp Rheumatol (1987) 0.85
Radiological assessment of outcome in rheumatoid arthritis. Br J Rheumatol (1988) 0.85
Self-referral of symptoms (SOS) follow-up system of appointments for patients with uncertain diagnoses in rheumatology out-patients. Rheumatology (Oxford) (2005) 0.85
An unusual case of adult varicella-associated arthritis. Rheumatology (Oxford) (2000) 0.85
Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol (1999) 0.84
Behavioural toxicity of antidepressants with particular reference to moclobemide. Psychopharmacology (Berl) (1992) 0.84
Association between cigarette smoking and release of tumour necrosis factor alpha and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis. Rheumatology (Oxford) (2006) 0.84
The relationship between serial measures of disease activity and outcome in rheumatoid arthritis. Q J Med (1993) 0.84
Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations. Genes Chromosomes Cancer (1997) 0.84
Rheumatoid arthritis and chronic lymphatic leukaemia. Clin Exp Rheumatol (1990) 0.84
Comparison of breast and rectal cancer patients' quality of life: results of a four year prospective field study. Eur J Cancer Care (Engl) (2003) 0.84
The families of borderlines. A comparative study. Arch Gen Psychiatry (1980) 0.83
Sterno-costo-clavicular hyperostosis. Br J Clin Pract (1992) 0.83
Enthesopathy index in ankylosing spondylitis. Ann Rheum Dis (1987) 0.83
Prophylaxis for venous thromboembolism in head and neck surgery: the practice of otolaryngologists. J Laryngol Otol (1997) 0.82
Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: influence on disease outcome. Arthritis Rheum (1999) 0.82
Detection of tuberous sclerosis in parents by magnetic resonance imaging. Neurology (1991) 0.82
The development of three-dimensional range of motion measurement systems for clinical practice. Rheumatology (Oxford) (2001) 0.82